CClinicalTrials.gg
CompletedNCT00825292Updated Jan 21, 2009

Detection and Classification of Colon Polyps

A Phase 2 interventional study of Polp removal and identification and colon polyp removal in Colon Polyps, sponsored by Mayo Clinic. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2009-01-21.

Sponsored by Mayo Clinic · Phase 2, Interventional, and Diagnostic

Phase
Phase 2
Study type
Interventional
Enrollment
110
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Colon cancer is the third most common cancer in western society. To prevent colon cancer it is recommended for people to undergo a screening colonoscopy at the age of fifty. The purpose of the colonoscopy is to remove polyps, since some of these lesions are precancerous. Precancerous polyps are called adenomas. This method of prevention is effective, but the standard colonoscopy currently used does not detect all polyps. Studies have reported a polyp miss rate of about 24%. Furthermore, we are unable to distinguish precancerous polyps from benign polyps, also known as hyperplastic polyps, with standard colonoscopy. This results in all polyps being removed at time of colonoscopy, even the benign polyps.

To help improve the detection of colon polyps new endoscopic technologies have been developed. These technologies include high definition white light (HDWL)and high definition narrow band imaging (HDNBI). HDWL improves the overall resolution of the images seen during colonoscopy. HDNBI can help us better classify polyps by enhancing their tissue appearance as well as seeing small blood vessels and capillaries.

The goal of this study to determine if HDNBI imaging shows an increased polyp detection rate when compared to the current standard colonoscopy. In addition to develop a classification system to help better differentiate between precancerous polyps and their benign counterparts using HDWL and HDNBI.

Read the detailed description

II. Hypothesis:

  1. The use of NBI colonoscopy will reduce the miss rate for colon polyps compared to standard white light imaging.
  2. HDWl and HDNBI are more accurate than standard colonoscopy for the classification of adenomatous polyps in comparison to other non-premalignant polyps.

III. Specific Aims:

  1. Compare the miss rate of standard white light imaging compared to NBI for detection of colon polyps with NBI
  2. Estimate the accuracy of standard white light, HDWL and HDNBI imaging modes for the classification of adenomatous (premalignant) versus non-adenomatous (hyperplastic, inflammatory, normal) polyps.
  3. Examine the inter-observer agreement for classification of adenomatous versus non-adenomatous polyps based on standard, NBI and HDWL imaging.

IV. Research Design and Methods:

4.1 Study Design: A prospective phase II cross-over trial. Patients will undergo both procedures (standard, NBI) back to back under conscious sedation. The order of the procedure will be randomized.

4.2 Setting: The study will take place at Mayo Clinic Jacksonville, Division of Gastroenterology, an expert center in the diagnosis and treatment of colon polyps.

4.3 Study Subjects All patients scheduled for colonoscopy at Mayo Clinic Jacksonville will be screened for eligibility using inclusion and exclusion criteria. The patients that are deemed eligible will be offered participation in the study. Informed consent will be obtained and the participant will be registered in our database. Prior to consent the participant will be made aware of the investigative nature of the study, alternatives, risks, and benefits.

4.4 Eligibility Criteria

Inclusion Criteria:

  1. Age 18 years or older.
  2. Informed written consent.

Exclusion Criteria:

  1. History of inflammatory bowel disease.
  2. Patients with severe cardiopulmonary disease precluding colonoscopy.
  3. Presence of conditions not allowing for polypectomy or biopsy (e.g. coagulation disorder).
  4. Known familial polyposis syndrome (FAP, HNPCC, Juvenile polyposis, etc)
  5. Sub-optimal preparation for the procedure, which will be determined by patient history or based on the initial colonoscopy.
  6. Pregnancy

4.5 Procedure and Data Collections

A. Pre-procedure:

All patients will be prepared for colonoscopy with the standard preparation and will be scheduled to have the procedure at Mayo Clinic Jacksonville. The principal investigator (PI) will screen eligible patients based on medical history, physical exam and laboratory data on day of procedure.

Patients typically arrive at the registration area at least 60 minutes before start of scheduled procedure. A GI endoscopy nurse will prepare patients in the standard manner and intravenous access will be placed. Eligible patients will be offered informed consent by the study PI or designee. Patients who agree to participate in the study will sign informed consent and will be registered in the database. A log with only non-identifiable (e.g. patients # 1) will also be maintained of eligible patients who decline to participate. The GI endoscopy nurse will monitor patient's vitals before, during and after procedure as per standard protocol.

B. Procedure:

The exams will be performed back to back with a standard colonoscope and an ETMI colonoscope provided by Olympus. The order of the first and second procedure will be randomized according to a list prepared by the statistician using randomly permuted blocks to ensure equal numbers of patients are randomized to the two groups. All patients will be sedated with meperidine or fentanyl and midazolam to achieve conscious sedation. Each procedure will be preformed by a different endoscopist. The endoscopist will be either the P.I. supervised by a GI staff physician or solely by one of the five GI staff physicians. During the initial colonoscopy all visualized polyps will be noted, photographed, and removed. When the ETMI colonoscope is used, all polyps will be photographed using these modes (HDWL, HDNBI). The NBI portion of the exam will be performed using the MB-046 cap to further enhance stabilization of the focal length of the colonoscope.

The second procedure will be done with the same level of careful inspection as the first although we not specifically regiment the time of withdrawal beyond what the endoscopist feels is necessary for a careful examination. During the second colonoscopy all visualized polyps will be noted, photographed and removed. During the first procedure, the time will be evaluated with a stopwatch. The stopwatch will start when the endoscopist begins pull-back at the cecum and end when the scope is removed from the anal verge. The clock will be stopped during washing of the bowel, polypectomy, biopsy or any other therapeutic maneuver. At the end of the first procedure, the endoscopist will be informed of the withdrawal and inspection time and every effort will be made to match this to the second procedure. Time will be recorded similarly for the second procedure. Polyps will be classified as pedunculated, raised-sessile (rounded) or flat. Flat polyps will be further classified according to the Paris endoscopic classification 14.

C. Post-procedure:

After the procedure all patients will be brought to the recovery and monitored as per standard protocol. Participants will be given discharge instructions as per protocol and also be provided with information to contact the P.I. if any problems should occur. Any post procedure complication will be reviewed on weekly intervals.

02

Conditions studied

  • Colon Polyps

Keywords

  • colon polyps, colon adenomas
03

In context

Polyps

385 studies on the registry are indexed under Polyps; 59 are open to participants now.

This study's enrollment of 110 is below the median of 160 across 250 interventional studies indexed under Polyps.

Browse Polyps studies →

Lead sponsor

Mayo Clinic is the lead sponsor of 3,218 studies on the registry; 670 are open to participants now.

Of its 445 completed or terminated interventional studies of FDA-regulated products, 313 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Age 18 years or older.
  2. Informed written consent

Exclusion criteria

Exclusion Criteria:

  1. History of inflammatory bowel disease.
  2. Patients with severe cardiopulmonary disease precluding colonoscopy.
  3. Presence of conditions not allowing for polypectomy or biopsy (e.g. coagulation disorder).
  4. Known familial polyposis syndrome (FAP, HNPCC, Juvenile polyposis, etc)
  5. Sub-optimal preparation for the procedure, which will be determined by patient history or based on the initial colonoscopy.
  6. Pregnancy
05

Study design

Phase
Phase 2
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
110 participants (actual)

Study arms

  • Active comparator
    2

    HDNBI colonoscopy followed by standard white light colonoscopy

    Procedure: Polp removal and identification · Procedure: ETMI colonoscope (ETMI scope is a FDA approved device)

  • Active comparator
    1

    standard white light colonoscopy followed by HDNBI colonoscopy

    Procedure: colon polyp removal · Procedure: ETMI colonoscope (ETMI scope is a FDA approved device)

Interventions

  • ProcedurePolp removal and identification

    Identify polyp during colonoscopy then remove polyp

    Also known as: Colonoscopy with polypectomy

  • Procedurecolon polyp removal

    identify and remove polyp

    Also known as: Colonoscopy with polypectomy

  • ProcedureETMI colonoscope (ETMI scope is a FDA approved device)

    ETMI colonoscope used to identify colon polyps as compared to HD white light colonoscope identifying colon polyps.

    Also known as: Detecting and removing colon polyps

06

What researchers measure

Primary outcomes

  1. 1. Compare the miss rate of standard white light imaging compared to NBI for detection of colon polyps with NBI

    Time frame: 2 years

Secondary outcomes

  1. 2. Estimate the accuracy of standard white light, HDWL and HDNBI imaging modes for the classification of adenomatous (premalignant) versus non-adenomatous (hyperplastic, inflammatory, normal) polyps.

    Time frame: 2 years

07

Study locations

1 site
  • Mayo Clinic
    Jacksonville, Florida 32224, United States
08

References and documents

Publications

  • Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ; American Cancer Society. Cancer statistics, 2004. CA Cancer J Clin. 2004 Jan-Feb;54(1):8-29. doi: 10.3322/canjclin.54.1.8. PubMed 14974761 ↗
  • Morson BC. Precancerous and early malignant lesions of the large intestine. Br J Surg. 1968 Oct;55(10):725-31. doi: 10.1002/bjs.1800551003. No abstract available. PubMed 5681027 ↗
  • Morson B. President's address. The polyp-cancer sequence in the large bowel. Proc R Soc Med. 1974 Jun;67(6 Pt 1):451-7. No abstract available. PubMed 4853754 ↗
  • Cappell MS, Forde KA. Spatial clustering of multiple hyperplastic, adenomatous, and malignant colonic polyps in individual patients. Dis Colon Rectum. 1989 Aug;32(8):641-52. doi: 10.1007/BF02555767. PubMed 2752850 ↗
  • Rex DK, Chadalawada V, Helper DJ. Wide angle colonoscopy with a prototype instrument: impact on miss rates and efficiency as determined by back-to-back colonoscopies. Am J Gastroenterol. 2003 Sep;98(9):2000-5. doi: 10.1111/j.1572-0241.2003.07662.x. PubMed 14499778 ↗
  • Muto M, Katada C, Sano Y, Yoshida S. Narrow band imaging: a new diagnostic approach to visualize angiogenesis in superficial neoplasia. Clin Gastroenterol Hepatol. 2005 Jul;3(7 Suppl 1):S16-20. doi: 10.1016/s1542-3565(05)00262-4. PubMed 16012987 ↗
  • Kara MA, Peters FP, Rosmolen WD, Krishnadath KK, ten Kate FJ, Fockens P, Bergman JJ. High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett's esophagus: a prospective randomized crossover study. Endoscopy. 2005 Oct;37(10):929-36. doi: 10.1055/s-2005-870433. PubMed 16189764 ↗
  • Gross SA, Buchner AM, Crook JE, Cangemi JR, Picco MF, Wolfsen HC, DeVault KR, Loeb DS, Raimondo M, Woodward TA, Wallace MB. A comparison of high definition-image enhanced colonoscopy and standard white-light colonoscopy for colorectal polyp detection. Endoscopy. 2011 Dec;43(12):1045-51. doi: 10.1055/s-0030-1256894. Epub 2011 Oct 4. PubMed 21971929 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 21, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00825292
Lead sponsor
Mayo Clinic
First posted
Jan 21, 2009
Start date
Jul 2006
Primary completion
Dec 2008
Completion
Dec 2008
Last update
Jan 21, 2009

Study contacts

Seth A. Gross, M.D.
principal investigator · Mayo Clinic
Michael B. Wallace, M.D.
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion